Recent Developments in Blood Biomarkers in Neuro-oncology

被引：3
作者：
Foster, Jessica B. [1 ]
Koptyra, Mateusz P. [2 ]
Bagley, Stephen J. [3 ]
机构：
[1] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Oncol, Philadelphia, PA USA
[2] Childrens Hosp Philadelphia, Ctr Data Driven Discovery Biomed D3b, Philadelphia, PA USA
[3] Univ Penn, Hosp Univ Penn, Perelman Sch Med, Div Hematol Oncol, 10 Floor Perelman Ctr,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA
来源：
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS | 2023年 / 23卷 / 12期
关键词：
Biomarkers; Neuro-Oncology; Liquid Biopsy; cfDNA; Glioma; Blood; PLASMA; RNA; GLIOBLASTOMA; DNA; CELLS;
D O I：
10.1007/s11910-023-01321-y
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Purpose of ReviewGiven the invasive and high-risk nature of brain surgery, the need for non-invasive biomarkers obtained from the peripheral blood is greatest in tumors of the central nervous system (CNS). In this comprehensive review, we highlight recent advances in blood biomarker development for adult and pediatric brain tumors.Recent FindingsWe summarize recent blood biomarker development for CNS tumors across multiple key analytes, including peripheral blood mononuclear cells, cell-free DNA, cell-free RNA, proteomics, circulating tumor cells, and tumor-educated platelets. We also discuss methods for enhancing blood biomarker detection through transient opening of the blood-brain barrier.SummaryAlthough blood-based biomarkers are not yet used in routine neuro-oncology practice, this field is advancing rapidly and holds great promise for improved and non-invasive management of patients with brain tumors. Prospective and adequately powered studies are needed to confirm the clinical utility of any blood biomarker prior to widespread clinical implementation.
引用
收藏
页码：857 / 867
页数：11
相关论文
共 85 条
  • [1] Prognostic utility of lncRNAs (LINC00565 and LINC00641) as molecular markers in glioblastoma multiforme (GBM)
    Amer, Rehab G.
    El Arab, Lobna R. Ezz
    Ghany, Dalia Abd El
    Saad, Amr S.
    Bahie-Eldin, Nermean
    Swellam, Menha
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2022, 158 (03) : 435 - 444
  • [2] Variables that affect assays for plasma cytokines and soluble activation markers
    Aziz, N
    Nishanian, P
    Mitsuyasu, R
    Detels, R
    Fahey, JL
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1999, 6 (01) : 89 - 95
  • [3] Association of plasma cell-free DNA with survival in patients with IDH wild-type glioblastoma
    Bagley, Stephen J.
    Till, Jacob
    Abdalla, Aseel
    Sangha, Hareena K.
    Yee, Stephanie S.
    Freedman, Jake
    Black, Taylor A.
    Hussain, Jasmin
    Binder, Zev A.
    Brem, Steven
    Desai, Arati S.
    O'Rourke, Donald M.
    Long, Qi
    Nabavizadeh, Seyed Ali
    Carpenter, Erica L.
    [J]. NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [4] Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study
    Bagley, Stephen J.
    Nabavizadeh, S. Ali
    Mays, Jazmine J.
    Till, Jacob E.
    Ware, Jeffrey B.
    Levy, Scott
    Sarchiapone, Whitney
    Hussain, Jasmin
    Prior, Timothy
    Guiry, Samantha
    Christensen, Theresa
    Yee, Stephanie S.
    Nasrallah, MacLean P.
    Morrissette, Jennifer J. D.
    Binder, Zev A.
    O'Rourke, Donald M.
    Cucchiara, Andrew J.
    Brem, Steven
    Desai, Arati S.
    Carpenter, Erica L.
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (02) : 397 - 407
  • [5] Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer
    Bagley, Stephen J.
    Kothari, Shawn
    Aggarwal, Charu
    Bauml, Joshua M.
    Alley, Evan W.
    Evans, Tracey L.
    Kosteva, John A.
    Ciunci, Christine A.
    Gabriel, Peter E.
    Thompson, Jeffrey C.
    Stonehouse-Lee, Susan
    Sherry, Victoria E.
    Gilbert, Elizabeth
    Eaby-Sandy, Beth
    Mutale, Faith
    DiLullo, Gloria
    Cohen, Roger B.
    Vachani, Anil
    Langer, Corey J.
    [J]. LUNG CANCER, 2017, 106 : 1 - 7
  • [6] Highly Sensitive EGFRvIII Detection in Circulating Extracellular Vesicle RNA of Glioma Patients
    Batool, Syeda Maheen
    Muralidharan, Koushik
    Hsia, Tiffany
    Falotico, Sarah
    Gamblin, Austin S.
    Rosenfeld, Yulia B.
    Khanna, Sirena K.
    Balaj, Leonora
    Carter, Bob S.
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (18) : 4070 - 4082
  • [7] Full Spectrum Flow Cytometry as a Powerful Technology for Cancer Immunotherapy Research
    Bonilla, Diana L.
    Reinin, Gil
    Chua, Edmond
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 7
  • [8] Circulating tumor DNA sequencing provides comprehensive mutation profiling for pediatric central nervous system tumors
    Bonner, Erin R.
    Harrington, Robin
    Eze, Augustine
    Bornhorst, Miriam
    Kline, Cassie N.
    Gordish-Dressman, Heather
    Dawood, Adam
    Das, Biswajit
    Chen, Li
    Pauly, Rini
    Williams, P. Mickey
    Karlovich, Chris
    Peach, Amanda
    Howell, D'andra
    Doroshow, James
    Kilburn, Lindsay
    Packer, Roger J.
    Mueller, Sabine
    Nazarian, Javad
    [J]. NPJ PRECISION ONCOLOGY, 2022, 6 (01)
  • [9] Early diagnosis of brain tumours using a novel spectroscopic liquid biopsy
    Brennan, Paul M.
    Butler, Holly J.
    Christie, Loren
    Hegarty, Mark G.
    Jenkinson, Michael D.
    Keerie, Catriona
    Norrie, John
    O'Brien, Rachel
    Palmer, David S.
    Smith, Benjamin R.
    Baker, Matthew J.
    [J]. BRAIN COMMUNICATIONS, 2021, 3 (02)
  • [10] Cell-free plasma microRNAs that identify patients with glioblastoma
    Bustos, Matias A.
    Rahimzadeh, Negin
    Ryu, Suyeon
    Gross, Rebecca
    Tran, Linh T.
    Renteria-Lopez, Victor M.
    Ramos, Romela, I
    Eisenberg, Amy
    Hothi, Parvinder
    Kesari, Santosh
    Barkhoudarian, Garni
    Takasumi, Yuki
    Cobbs, Charles
    Kelly, Daniel F.
    Hoon, Dave S. B.
    [J]. LABORATORY INVESTIGATION, 2022, 102 (07) : 711 - 721
123456789